Nexentis Technologies Inc. Segments Disclosure
NOTE 23 – SEGMENT REPORTING
| A. | Information about reported segment profit or loss and assets |
This segment’s structure reflects the financial information and reports used by the Company’s management, specifically its chief operating decision maker (“CODM”), to make decisions regarding the Company’s business, including resource allocations and performance assessments, as well as the current operating focus in compliance with ASC 280, Segment Reporting. The Company’s reportable segments are not aggregated.
The Company reports segment information based on the management approach, which designates the internal reporting used by the Chief Operating Decision Maker (“CODM”), the Company’s Chief Executive Officer and the Chairman of the Board, for making decisions and assessing performance as the source of the Company’s reportable segments. The CODM allocate resources and assesses the performance of each operating segment based on potential business opportunities, historical and potential future sales and operating expenses.
As of December 31, 2024, the Company had two reportable segments: (i) Pathogen prevention and prolong shelf life, and (ii) the N2O emissions Global warming solutions. The Pathogen prevention operating segment consisted of Save Food Ltd. and the Global warming solutions operating segment consisted of NTWO OFF Ltd.
As of December 31, 2025, the Company no longer operates in the N₂O emissions Global warming solutions segment, following the sale of NTWO OFF Ltd. in April 2025. Accordingly, this activity has been classified as a discontinued operation in accordance with ASC 205-20 and is excluded from continuing operations for all periods presented. In addition, Save Foods Ltd.’s operations were classified as discontinued operations as the Company is committed to a plan to sell the subsidiary and classified its assets and liabilities as held for sale as of December 31, 2025. The disposal represents a strategic shift that has a major effect on the Company’s operations and financial results. As a result of the disposal of NTWO OFF Ltd., the classification of Save Foods Ltd.’s operations as discontinued operations, and the acquisition of MitoCareX in October 2025, the Company reassessed its operating and reportable segments in accordance with ASC 280, Segment Reporting. As a result, the Company determined that it has two reportable segments as of December 31, 2025: (i) Biotechnology activity, and (ii) Renewable energy projects. The Biotechnology operating segment consists of MitoCareX from the acquisition date, and the Renewable energy projects operating segment consists of NITO Renewable Energy, Inc. and Solar photovoltaic joint venture project.
The CODM evaluates performance and allocates resources based primarily on segment operating loss. Prior period segment information has been recast to conform to the current year presentation.
NEXENTIS TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(USD in thousands, except share and per share data)
NOTE 23 – SEGMENT REPORTING (continue)
The following table presents information about the Company’s reportable segments for the years ended December 31, 2025 and 2024:
| Year ended | ||||||||
| December 31 | ||||||||
| 2025 | 2024 | |||||||
| Revenue from biotechnology activity | ||||||||
| Cost related to biotechnology activity (*) | (169 | ) | ||||||
| Salaries and related expenses related to biotechnology activity | (157 | ) | ||||||
| Operating loss from Biotechnology activity | (326 | ) | ||||||
| Revenue from renewable energy projects | ||||||||
| Cost related to renewable energy projects (**) | (340 | ) | ||||||
| Operating loss from renewable energy projects | (340 | ) | ||||||
| Professional services | (1,727 | ) | (1,791 | ) | ||||
| Share base compensation | (2,386 | ) | (1,055 | ) | ||||
| Change in fair value of contingent consideration | 1,136 | |||||||
| Depreciation | (1 | ) | ||||||
| Other general and administrative expenses | (586 | ) | (437 | ) | ||||
| Total Operating loss | (4,230 | ) | (3,283 | ) | ||||
| Interest of loans | (77 | ) | ||||||
| Financing expenses, net | (1,468 | ) | (252 | ) | ||||
| Other income | 1,811 | 428 | ||||||
| Changes in fair value of investments measured under the fair value option | 351 | (1,212 | ) | |||||
| Net loss before tax | (3,613 | ) | (4,319 | ) | ||||
| Income taxes | 18 | |||||||
| Net loss | (3,595 | ) | (4,319 | ) | ||||
| (*) | Costs related to biotechnology activity primarily consist of subcontractors engaged in research and development activities. |
| (**) | Costs related to renewable energy projects primarily consist of expenses incurred for subcontractors providing professional services. |
| B. | Information on Long-Lived Assets - Property, Plant and Equipment Intangible Assets and ROU assets by geographic areas: |
The following table presents the locations of the Company’s long-lived assets as of December 31, 2025 and 2024:
| Year ended December 31 | ||||||||
| 2025 | 2024 | |||||||
| Israel | 4,453 | |||||||
| United States | 16 | 8 | ||||||
| Italy | 725 | |||||||
| 5,194 | 8 | |||||||
NEXENTIS TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(USD in thousands, except share and per share data)
Want the next Nexentis Technologies Inc. segments disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment Nexentis Technologies Inc.'s next filing hits EDGAR. No credit card, your email never gets sold.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 31, 2026 | Showing above |
| 2024 | Mar 31, 2025 | |
| 2023 | Apr 1, 2024 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.